| 511.2 | V06DE | náhrady mléka obsahující bílkovinu kravského mléka, s nízkým obsahem laktózy | p.o. | 100 | GM | 33,80 | L/J11 | ||||
| 61450 | NUTRILON LOW-LACTOSE | plv 1×400gm | NUT | NL | |||||||
| 511.3 | V06DE | náhrady mléka obsahující proteinové hydrolyzáty | p.o. | 100 | GM | 30,00 | L/J11 | ||||
| 511.4 | V06DE | náhrady mléka obsahující proteinové hydrolyzáty, s nízkým obsahem laktózy | p.o. | 100 | GM | 65,00 | L/J11 | ||||
| 512 | V06DF | náhrady mléka obsahující sojovou bílkovinu | p.o. | L/J11 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 512.1 | V06D | náhrady mléka obsahující sojovou bílkovinu | p.o. | 100 | GM | 28,60 L/J11 | |||||
| 75946 | ISOMIL | plv 1×400gm | ABB | USA | |||||||
| 513 | V06DX | jiné kombinace přípravků pro výživu | p.o. | L/J11 | |||||||
| 513.1 | V06DX | MCT olej | p.o. | 100 | ML | 105,50 | L/J11 | ||||
| 95198 | MCT OIL | sol 1×946ml | BMS | USA | |||||||
| 514 | V07AB | rozpouštědla a ředidla, včetně irigačních roztoků | parent. | ||||||||
| 514.1 | V07AB | voda na injekci (do 2 ml v jedné ampuli včetně) | parent. | 1 | ML | 2,95 | |||||
| 00383 | AQUA PRO INJECTIONE BIOTIKA | inj 10×2ml | BTA | SK | |||||||
| 514.2 | V07AB | voda na injekci (nad 2 do 10 ml v jedné ampuli včetně) | parent. | 10 | ML | 3,80 | |||||
| 00387 00388 55807 83699 83700 | AQUA PRO INJECTIONE BIOTIKA AQUA PRO INJECTIONE BIOTIKA AQUA PRO INJECTIONE BIOTIKA WATER FOR INJECTION B.P.CORE WATER FOR INJECTION B.P.CORE | inj 10×10ml inj 50×10ml inj 100×10ml inj 50×5ml inj 50×10ml | BTA BTA BTA CPL CPL | SK SK SK IND IND | |||||||
| 514.3 | V07AB | voda na injekci nad 10 ml v jedné ampuli nebo lahvi | parent. | 100 | ML | 12,45 | |||||
| 00657 66642 67802 69789 70528 89245 91876 92782 92783 53364 53363 97727 97726 69788 | AQUA PRO INJECTIONE IMUNA AQUA PRO INJECTIONE CIV AQUA PRO INJECTIONE IMUNA AQUA PRO INJECTIONE ARDEAPHARMA AQUA PRO INJECTIONE MEDICAMENTA AQUA PRO INJECTIONE ARDEAPHARMA AQUA PRO INJECTIONE INFUSIA AQUA PRO INJECTIONE MEDIEKOS AQUA PRO INJECTIONE MEDIEKOS AQUA PRO INJECTIONE INFUSIA AQUA PRO INJECTIONE INFUSIA WATER FOR INJECTION BIEFFE WATER FOR INJECTION BIEFFE AQUA PRO INJECTIONE ARDEAPHARMA | inf 1×400ml sol 1×500ml inf 1×500ml inf 1×500ml inf 1×500ml inf 1×400ml sol 1×500ml sol 1×1000ml (vak) sol 1×2000ml (vak) sol 1×500ml sol 1×250ml inf 1×500ml(sklo) inf 1×250ml(sklo) inf 1×300ml | IMA CIV IMA ARD MVM ARD IHO MKS MKS IHO IHO BFF BFF ARD | SK CZ SK CZ CZ CZ CZ CZ CZ CZ CZ I I CZ | |||||||
| 515 | V08A | rozpustné nefrotropní RTG kontrastní látky | p.o. | K | |||||
|---|---|---|---|---|---|---|---|---|---|
| 515.1 | V08AA05 | kyselina ioxitalamová | p.o. | 10 | ML | 60,55 | K | ||
| 93497 | TELEBRIX GASTRO | sol 1×100ml | BGL | D | |||||
| 515.2 | V08AB04 | iopamidol | p.o. | 10 | ML | 60,55 | K | ||
| 516 | V08AA | rozpustné nefrotropní hyperosmolární RTG kontrastní látky | parent. | K | |||||
| 516.1 | V08A | meglumin amidotrizoát | parent. | 10 | ML | 75,20 | K | ||
| 516.2 | V08AA03 | iodamid (koncentrace 300 mg I/ml) | parent. | 10 | ML | 42,00 | K | ||
| 516.3 | V08AA03 | iodamid (koncentrace 380 mg I/ml) | parent. | 10 | ML | 46,00 | K | ||
| 516.4 | V08AA03 | iodamid (koncentrace 410 mg I/ml) | parent. | 10 | ML | 89,40 | K | ||
| 516.5 | V08AA05 | kyselina ioxitalamová (koncentrace 300 mg I/ml) | parent. | 10 | ML | 51,85 | K | ||
| 92348 | TELEBRIX N 300 | inj 6×20ml | LEX | CZ | |||||
| 516.6 | V08AA05 | kyselina ioxitalamová (koncentrace 350 mg I/ml a více) | parent. | 10 | ML | 60,00 | K | ||
| 92349 92350 | TELEBRIX N 350 TELEBRIX N 380 | inj 6×20ml inj 6×20ml | LEX LEX | CZ CZ | |||||
| 517 | V08AB | rozpustné nefrotropní nízkoosmolání RTG kontrastní látky | parent. | K | |||||
| Vyšetření iotrolanem ordinuje rentgenolog: a) pro intrathekální podání, b) v ostatních případech po předchozím schválení revizním lékařem. | |||||||||
| 517.1 | V08AB02 | iohexol (koncentrace 180 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 248,85 | K | ||
| 87801 87802 | OMNIPAQUE 180 OMNIPAQUE 180 | inj 10×10ml inj 10×15ml | NYI NYI | N N | |||||
| 517.2 | V08AB02 | iohexol (koncentrace 240 mg I/ml, od 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 214,70 | K | ||
| 04337 87602 | OMNIPAQUE 240 OMNIPAQUE 240 | inj 25×20ml inj 6×20ml | NYI NYI | N N | |||||
| 517.3 | V08AB02 | iohexol (koncentrace 240 mg I/ml, do 15 ml v jedné ampuli včetně) | parent. | 10 | ML | 297,30 | K | ||
| 94219 | OMNIPAQUE 240 | inj 10×10ml | NYI | N | |||||
| 517.4 | V08AB02 | iohexol (koncentrace 240 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 165,15 K | |||
| 04338 04339 | OMNIPAQUE 240 OMNIPAQUE 240 | inj 10×50ml inj 6×200ml | NYI NYI | N N | |||||
| 517.5 | V08AB02 | iohexol (koncentrace 300 mg I/ml, od 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 249,60 | K |
| 04328 04329 | OMNIPAQUE 300 OMNIPAQUE 300 | inj 6×20ml inj 25×20ml | NYI NYI | N N | |||
| 517.6 | V08AB02 | iohexol (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 345,60 | K |
| 94220 | OMNIPAQUE 300 | inj 10×10ml | NYI | N | |||
| 517.7 | V08AB02 | iohexol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 192,00 | K |
| 04330 62466 87600 | OMNIPAQUE 300 OMNIPAQUE 300 OMNIPAQUE 300 | inj 10×50ml (sklo) inj 10×50ml (pp) inj 10×100ml | NYI NYI NYI | N N N | |||
| 517.8 | V08AB02 | iohexol (koncentrace 350 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 278,85 | K |
| 04332 04333 | OMNIPAQUE 350 OMNIPAQUE 350 | inj 6×20ml inj 25×20ml | NYI NYI | N N | |||
| 517.9 | V08AB02 | iohexol (koncentrace 350 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 214,50 | K |
| 87603 62467 04335 75261 | OMNIPAQUE 350 OMNIPAQUE 350 OMNIPAQUE 350 OMNIPAQUE 350 | inj 10×50ml (sklo) inj 10×50ml (pp) inj 10×100ml inj 6×200ml | NYI NYI NYI NYI | N N N N | |||
| 517.10 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 255,10 | K |
| 88645 | HEXABRIX 320(HEXABRIX 85) | inj 20ml | BGL | D | |||
| 517.11 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 201,25 | K |
| 517.12 | V08AB04 | iopamidol (koncentrace 200 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 261,15 | K |
| 517.13 | V08AB04 | iopamidol (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 322,80 | K |
| 517.14 | V08AB04 | iopamidol (koncentrace 300 mg I/ml, od 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 200,20 | K |
| 97773 | IOPAMIRO 300 | inj 10×30ml | BCC | I | |||
| 517.15 | V08AB04 | iopamidol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 182,70 | K |
| 517.16 | V08AB04 | iopamidol (koncentrace 370 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 394,10 | K |
| 517.17 | V08AB04 | iopamidol (koncentrace 370 mg I/ml, od 15 do 30 ml v jedné ampuli včetně) | parent. | 10 | ML | 242,20 | K |
| 517.18 | V08AB04 | iopamidol (koncentrace 370 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 195,00 | K |
| 517.19 | V08AB05 | iopromid (koncentrace 240 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 165,15 | K |
| 77015 93623 | ULTRAVIST-240 ULTRAVIST-240 | inj 10×50ml inj 1×50ml | SAG SAG | D D | |||
| 517.20 | V08AB05 | iopromid (koncentrace 300 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 249,60 | K |
| 77024 | ULTRAVIST-300 | inj 10×20ml | SAG | D | |||
| 517.21 | V08AB05 | iopromid (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 192,00 | K |
| 77017 77016 93627 93628 | ULTRAVIST-300 ULTRAVIST-300 ULTRAVIST-300 ULTRAVIST-300 | inj 10×100ml inj 10×50ml inj 1×50ml inj 1×100ml | SAG SAG SAG SAG | D D D D | |||
| 517.22 | V08AB05 | iopromid (koncentrace 370 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 223,30 | K |
| 77019 77020 77018 93625 93626 93624 | ULTRAVIST-370 ULTRAVIST-370 ULTRAVIST-370 ULTRAVIST-370 ULTRAVIST-370 ULTRAVIST-370 | inj 10×100ml inj 10×200ml inj 10×50ml inj 1×100ml inj 1×200ml inj 1×50ml | SAG SAG SAG SAG SAG SAG | D D D D D D | |||
| 517.23 | V08AB06 | iotrolan (koncentrace 240 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 462,70 | K/P |
| 96349 | ISOVIST 240 | inj 1×10ml 240mg/ml | SAG | D | |||
| 517.24 | V08AB06 | iotrolan (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 575,30 | K/P |
| 96351 | ISOVIST 300 | inj 1×10ml 300mg/ml | SAG | D | |||
| 517.25 | V08AB07 | ioversol (koncentrace 160 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 128,65 | K |
| 68772 | OPTIRAY 160 | inj 10×50ml | MME | D | |||
| 517.26 | V08AB07 | ioversol (koncentrace 240 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 165,15 | K |
| 68922 98298 | OPTIRAY 240 OPTIRAY 240 | inj 10×100ml inj 10×50ml | MME MME | D D | |||
| 517.27 | V08AB07 | ioversol (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 345,60 | K |
| 92365 | OPTIRAY 300 | inj 10×10ml | MME | D | |||
| 517.28 | V08AB07 | ioversol (koncentrace 300 mg I/ml, od 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 249,60 | K |
| 68923 | OPTIRAY 300 | inj 10×20ml | MME | D | |||
| 517.29 | V08AB07 | ioversol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 192,00 | K |
| 68850 92366 92368 92369 92367 | OPTIRAY 300 OPTIRAY 300 OPTIRAY 300 OPTIRAY 300 OPTIRAY 300 | inj 10×50ml inj 10×75ml inj 10×150ml inj 10×200ml inj 10×100ml | MME MME MME MME MEE | D D D D D | |||
| 517.30 | V08AB07 | ioversol (koncentrace 320 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 201,25 | K |
| 68773 | OPTIRAY 320 | inj 10×50ml | MME | D | |||
| 517.31 | V08AB07 | ioversol (koncentrace 350 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 278,85 | K |
| 92370 | OPTIRAY 350 | inj 10×30ml | MME | D | |||
| 517.32 | V08AB07 | ioversol (koncentrace 350 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 214,50 | K |
| 68925 92371 68851 | OPTIRAY 350 OPTIRAY 350 OPTIRAY 350 | inj 10×100ml inj 10×200ml inj 10×50ml | MME MME MME | D D D | |||
| 517.33 | V08AB10 | iomeprol (koncentrace 150 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 124,80 | K |
| 517.34 | V08AB10 | iomeprol (koncentrace 200 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 147,65 | K |
| 517.35 | V08AB10 | iomeprol (koncentrace 250 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 169,55 | K |
| 517.36 | V08AB10 | iomeprol (koncentrace 300 mg I/ml, do 30 ml v ampuli) | parent. | 10 | ML | 249,60 | K |
| 517.37 | V08AB10 | iomeprol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 192,00 | K |
| 517.38 | V08AB10 | iomeprol (koncentrace 350 mg I/ml, do 30 ml v ampuli) | parent. | 10 | ML | 278,85 | K |
| 517.39 | V08AB10 | iomeprol (koncentrace 350 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 214,50 | K |
| 517.40 | V08AB10 | iomeprol (koncentrace 400 mg I/ml, do 30 ml v ampuli) | parent. | 10 | ML | 307,80 | K |
| 517.41 | V08AB10 | iomeprol (koncentrace 400 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 236,75 | K |
| 517.42 | V08AB9 | iodixanol (koncentrace 150 mg I/ml, nad 50 ml v jedné ampuli) | parent. | 10 | ML | 128,65 | K |
| 517.43 | V08AB9 | iodixanol (koncentrace 270mg I/ml, do 30 ml v jedné ampuli) | parent. | 10 | ML | 249,60 | K |
| 517.44 | V08AB9 | iodixanol (koncentrace 270mg I/ml, nad 50 ml v jedné ampuli) | parent. | 10 | ML | 192,00 | K |
| 517.45 | V08AB9 | iodixanol (koncentrace 320mg I/ml, do 30 ml v jedné ampuli) | parent. | 10 | ML | 278,85 | K |
| 517.46 | V08AB9 | iodixanol (koncentrace 320mg I/ml, nad 50 ml v jedné ampuli) | parent. | 10 | ML | 214,50 | K |
| 518 | V08AC | Rozpustné hepatotropní RTG kontrastní látky | parent. | K | |||
|---|---|---|---|---|---|---|---|
| 518.1 | V08AC | kyselina iodoxamová (koncentrace 183 mg I/ml) | parent. | 10 | ML | 75,95 | K |
| 518.2 | V08AC | kyselina iodoxamová (koncentrace 45 mg I/ml) | parent. | 10 | ML | 38,25 | K |
| 518.3 | V08AC04 | adipiodon | parent. | 10 | ML | 40,25 | K |
| 03394 | ENDOBIL PRO INF. I. V. | inf 100ml | BCC | I |
| 519 | V08AD | nerozpustné RTG kontrastní látky | parent. | K | ||||
|---|---|---|---|---|---|---|---|---|
| 519.1 | V08AD | iopydol + iopyron | parent. | 10 | ML | 307,60 | K | |
| 519.2 | V08AD01 | ethylestery jodovaných mastných kyselin | parent. | 10 | ML | 473,15 | K | |
| 03552 | LIPIODOL ULTRA-FLUID | inj 5×5ml | BGL | D | ||||
| 520 | V08BA | RTG kontrastní přípravky obsahující síran barnatý | p.o. | K | ||||
| 520.1 | V08BA | síran barnatý | p.o. | 100 | GM | 34,05 | K | |
| 06303 94370 | MICROPAQUE PRONTOBARIO 60% | sus 1×2000ml sus 1×5lt | GUE BCC | D I | ||||
| 520.2 | V08BA | síran barnatý (lékové formy pro CT) | p.o. | 7.5 | GM | 165,55 | K | |
| 44367 | MICROPAQUE CT | sus 1×2000ml/100gm | GUE | D | ||||
| 520.3 | V08BA | síran barnatý (lékové formy kolon) | p.o. | 100 | GM | 46,80 | K | |
| 91066 | MICROPAQUE COLON | plv 1×800gm | GUE | D | ||||
| 520.4 | V08BA | síran barnatý (lékové formy pasty) | p.o. | 100 | GM | 96,75 | K | |
| 62535 | PRONTOBARIO ESOFAGO | sus 6×250ml (tuba) | BCC | I | ||||
| 520.5 | V08BA | síran barnatý (lékové formy HD) | p.o. | 100 | GM | 38,95 | K | |
| 06304 | MICROPAQUE H.D. ORAL | plv 1×416gm | GUE | D | ||||
| 521 | V08CA | paramagnetické kontrastní látky | parent. | K | ||||
| 521.1 | V08CA01 | dimeglumin gadopentetat (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 2024,00 | K | |
| 75660 75659 | MAGNEVIST MAGNEVIST | inj 1×10ml inj 1×5ml | SAG SAG | D D | ||||
| 521.2 | V08CA01 | dimeglumin gadopentetat (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1882,35 | K | |
| 96352 | MAGNEVIST | inj 1×20ml | SAG | D | ||||
| 521.3 | V08CA03 | gadodiamid (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 2024,00 | K | |
| 55822 78815 | OMNISCAN 0.5MMOL/ML OMNISCAN 0.5MMOL/ML | inj 10×5ml inj 10×10ml | NYI NYI | N N | ||||
| 521.4 | V08CA03 | gadodiamid (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1882,35 | K | |
| 78816 78817 | OMNISCAN 0.5MMOL/ML OMNISCAN 0.5MMOL/ML | inj 10×15ml inj 10×20ml | NYI NYI | N N | ||||